Deep Carious LesionPhase 4NCT03791255
Light Cured Resin Modified Calcium Silicate Versus Light Cured Calcium Hydroxide in Indirect Pulp Treatment of Primary Molars
A Phase 4 study testing Calcium silicate liner and Calcium hydroxide liner in people with Deep Carious Lesion and Indirect Pulp Treatment, run by Cairo University.
Trial summary
The objective of this study is to explore if light cured resin modified Calcium silicate could result in better clinical and radiographic success if compared to light cured Calcium hydroxide when used in indirect pulp capping treatment in primary molars. Read more about this study
- Who is it for?
- Ages 4 to 7 yearsHealthy volunteers can take part
- Conditions the study is for
- Deep Carious Lesion, Indirect Pulp Treatment
- What is being tested?
- Calcium silicate liner and Calcium hydroxide liner
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 46 participants
- Where
- No sites listed yet
- Study dates
- Feb 2019to Feb 2021
- Phase
- Phase 4
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 4 to 7 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Medically free children.
- Age range from 4-7 years.
- Presence of lower second primary molars with deep carious occlusal lesion.
- No history of spontaneous pain (reversible pulpitis).
- Clinically: Absence of swelling, sinus, fistula, pain on percussion and tooth mobility.
- Radiographically: Absence of radiolucent lesions at furcation or periapical region and absence of internal or external root resorption.
Who cannot join
- Uncooperative children.
- Any unmet previous criterion.
About this study
Official title: Clinical and Radiographic Evaluation of Light Cured Resin Modified Calcium Silicate Versus Light Cured Calcium Hydroxide in Indirect Pulp Treatment of Primary Molars
The objective of this study is to explore if light cured resin modified Calcium silicate could result in better clinical and radiographic success if compared to light cured Calcium hydroxide when used in indirect pulp capping treatment in primary molars.
Read the detailed description
To evaluate clinical and radiographic success of resin modified calcium silicate in comparison to light cured calcium hydroxide as indirect pulp capping materials in primary molars.
P: Children aged (4-7 years) with deep carious lesions in lower primary second molars indicated for indirect pulp treatment.
I: Indirect pulp treatment using light cured resin modified Calcium Silicate (TheraCal).
C: Indirect pulp treatment using light cured Calcium Hydroxide. O: clinical and radiographic success.
- Conditions
- Deep Carious Lesion, Indirect Pulp Treatment
- Being tested
- Calcium silicate liner, Calcium hydroxide liner
- Keywords
- resin modified calcium silicate, indirect pulp treatment, primary molars
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Calcium silicate linerDrug
new light-cured resin-modified calcium silicate-filled base/ liner material designed for direct and indirect pulp capping
Calcium hydroxide linerDrug
Calcium hydroxide is the gold standard for pulp capping, allows for the formation of a reparative dentin bridge
| Study group | Role | What they receive |
|---|---|---|
| Resin Modified Calcium Silicate | Experimental | light-cured resin-modified calcium silicate-filled base/ liner material designed for direct and indirect pulp capping Receives: Drug: Calcium silicate liner |
| Light Cured Calcium Hydroxide | Active comparator | gold standard for pulp capping, It allows for the formation of a reparative dentine bridge through cellular differentiation, extracellular matrix secretion and subsequent mineralization. Receives: Drug: Calcium hydroxide liner |
What is being measured
The primary outcome is the main question the study is designed to answer.
Postoperative pain
Pain questionnaire (binary yes/no)
Measured: 1 month
Postoperative pain
Pain questionnaire (binary yes/no)
Measured: 3 months
Postoperative pain
Pain questionnaire (binary yes/no)
Measured: 6 months
Postoperative pain
Pain questionnaire (binary yes/no)
Measured: 12 months
Secondary outcomes (28)
Swelling
Visual examination by the operator (binary yes/no)
Measured: 1 month
Swelling
Visual examination by the operator (binary yes/no)
Measured: 3 months
Swelling
Visual examination by the operator (binary yes/no)
Measured: 6 months
Swelling
Visual examination by the operator (binary yes/no)
Measured: 12 months
Sinus or fistula
Visual examination by the operator (binary yes/no)
Measured: 1 month
Sinus or fistula
Visual examination by the operator (binary yes/no)
Measured: 3 months
Sinus or fistula
Visual examination by the operator (binary yes/no)
Measured: 6 months
Sinus or fistula
Visual examination by the operator (binary yes/no)
Measured: 12 months
Tooth mobility
back of the mirror to check mobility (binary yes/no)
Measured: 1 month
Tooth mobility
back of the mirror to check mobility (binary yes/no)
Measured: 3 months
Tooth mobility
back of the mirror to check mobility (binary yes/no)
Measured: 6 months
Tooth mobility
back of the mirror to check mobility (binary yes/no)
Measured: 12 months
pain on percussion
back of the mirror to check pain on percussion (binary yes/no)
Measured: 1 month
pain on percussion
back of the mirror to check pain on percussion (binary yes/no)
Measured: 3 months
pain on percussion
back of the mirror to check pain on percussion (binary yes/no)
Measured: 6 months
pain on percussion
back of the mirror to check pain on percussion (binary yes/no)
Measured: 12 months
Occurrence of radiolucent lesions at furcation or periapical region
(binary yes/no)
Measured: 1 months
Occurrence of radiolucent lesions at furcation or periapical region
(binary yes/no)
Measured: 3 months
Occurrence of radiolucent lesions at furcation or periapical region
(binary yes/no)
Measured: 6 months
Occurrence of radiolucent lesions at furcation or periapical region
(binary yes/no)
Measured: 12 months
widening in the periodontal membrane space
(binary yes/no)
Measured: 1 month
widening in the periodontal membrane space
(binary yes/no)
Measured: 3 months
widening in the periodontal membrane space
(binary yes/no)
Measured: 6 months
widening in the periodontal membrane space
(binary yes/no)
Measured: 12 months
presence of internal or external root resorption
(binary yes/no)
Measured: 1 month
presence of internal or external root resorption
(binary yes/no)
Measured: 3 months
presence of internal or external root resorption
(binary yes/no)
Measured: 6 months
presence of internal or external root resorption
(binary yes/no)
Measured: 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jan 2019
- Study startFeb 2019 (estimated)
- Primary completionFeb 2020 (estimated)
- Study completionFeb 2021 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Deep Carious LesionStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 46 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Yasmine Ashraf Elbanna, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03791255
- Sponsor's protocol ID
- Indirect pulp primary molars
- Status last verified
- Jan 2019
- First submitted
- 27 Dec 2018
- Last updated
- 15 Jan 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No